Synergy between PI3K/Akt and Raf/MEK/ERK Pathways in IGF-1R Mediated Cell Cycle Progression and Prevention of Apoptosis in Hematopoietic Cells

The insulin like growth factor-1 (IGF-1) receptor (R) induced PI3K/Akt signal transduction cascade has critical roles in prevention of apoptosis and regulation of cell cycle progression. Here, we discuss the effects of IGF-1R-mediated signal transduction on hematopoietic cells which normally require interleukin-3 (IL-3) for growth and prevention of apoptosis. Cytokine-dependent FDC-P1 hematopoietic cells were conditionally transformed to grow in response to overexpression of IGF-1R in the presence of IGF-1. When these cells were deprived of IL-3 or IGF-1 for 24 hrs, they exited the cell cycle, activated caspase 3 and underwent apoptosis. The effects of inhibitors which targeted the PI3K/Akt and Raf/MEK/ERK pathways were determined. When the cells were cultured with IGF-1 and either PI3K or MEK inhibitors, cell cycle progression and DNA synthesis were inhibited and caspase 3 activity and apoptosis were induced. Co-inhibition of both pathways synergized to prevent cell cycle progression, inhibit DNA synthesis and induce apoptosis. These inhibitors had more apoptotic inducing effects when the cells were grown in response to IGF-1 than IL-3, indicating that IL-3 can induce additional anti-apoptotic pathways. These results demonstrate that the PI3K/Akt and Raf/MEK/ERK pathways are intimately involved in IGF-1R-mediated cell cycle progression and prevention of apoptosis in hematopoietic cells.

[1]  J. McCubrey,et al.  B-Raf and Insulin Synergistically Prevent Apoptosis and Induce Cell Cycle Progression in Hematopoietic Cell , 2004, Cell cycle.

[2]  F. E. Bertrand,et al.  JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis , 2004, Leukemia.

[3]  J. McCubrey,et al.  Differential effects of kinase cascade inhibitors on neoplastic and cytokine-mediated cell proliferation , 2003, Leukemia.

[4]  J. McCubrey,et al.  Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention , 2003, Leukemia.

[5]  J. McCubrey,et al.  Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy , 2003, Leukemia.

[6]  J. McCubrey,et al.  Targeting the Raf kinase cascade in cancer therapy – novel molecular targets and therapeutic strategies , 2002, Expert opinion on therapeutic targets.

[7]  J. McCubrey,et al.  Raf-Induced Cell Cycle Progression in Human TF-1 Hematopoietic Cells , 2002, Cell cycle.

[8]  K. M. Nicholson,et al.  The protein kinase B/Akt signalling pathway in human malignancy. , 2002, Cellular signalling.

[9]  W. Fiedler,et al.  Expression of a mutated form of the p85α regulatory subunit of phosphatidylinositol 3-kinase in a Hodgkin's lymphoma-derived cell line (CO) , 2002, Leukemia.

[10]  J. McCubrey,et al.  The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia , 2002, Leukemia.

[11]  P. Doshi,et al.  Extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways cooperate in mediating cytokine-induced proliferation of a leukemic cell line , 2002, Leukemia.

[12]  G. G. Choudhury.  Akt Serine Threonine Kinase Regulates Platelet-derived Growth Factor-induced DNA Synthesis in Glomerular Mesangial Cells , 2001, The Journal of Biological Chemistry.

[13]  M. Mann,et al.  p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. McCubrey,et al.  Enhanced ability of daniplestim and myelopoietin-1 to suppress apoptosis in human hematopoietic cells , 2001, Leukemia.

[15]  J. McCubrey,et al.  P21Cip1 induced by Raf is associated with increased Cdk4 activity in hematopoietic cells , 2001, Oncogene.

[16]  J. McCubrey,et al.  Suppression of apoptosis: role in cell growth and neoplasia , 2001, Leukemia.

[17]  M. J. Fry.  Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play? , 2001, Breast Cancer Research.

[18]  J. McCubrey,et al.  Synergistic effects of pi3k/akt on abrogation of cytokine-dependency induced by oncogenic raf. , 2001, Advances in enzyme regulation.

[19]  J. McCubrey,et al.  Effects of inducible MEK1 activation on the cytokine dependency of lymphoid cells , 2001, Leukemia.

[20]  Ulf R. Rapp,et al.  Apoptosis Suppression by Raf-1 and MEK1 Requires MEK- and Phosphatidylinositol 3-Kinase-Dependent Signals , 2001, Molecular and Cellular Biology.

[21]  I. Leuschner,et al.  Overexpression of phosphatidylinositol 3-kinase in human lung cancer , 2001, Langenbeck’s Archives of Surgery.

[22]  T. Shimizu,et al.  Complex regulation of CDK2 and G1 arrest during neuronal differentiation of human prostatic cancer TSU-Prl cells by staurosporine. , 2001, Anticancer research.

[23]  J. McCubrey,et al.  Interactions between the PI3K and Raf signaling pathways can result in the transformation of hematopoietic cells. , 2001, Cancer detection and prevention.

[24]  J. Lammers,et al.  Forkhead Transcription Factor FKHR-L1 Modulates Cytokine-Dependent Transcriptional Regulation of p27KIP1 , 2000, Molecular and Cellular Biology.

[25]  M. Lawlor,et al.  Insulin-Like Growth Factor-Mediated Muscle Cell Survival: Central Roles for Akt and Cyclin-Dependent Kinase Inhibitor p21 , 2000, Molecular and Cellular Biology.

[26]  J. McCubrey,et al.  Kinases: positive and negative regulators of apoptosis , 2000, Leukemia.

[27]  A. Tolkovsky,et al.  Phosphorylation of the pro-apoptotic protein BAD on serine 155, a novel site, contributes to cell survival , 2000, Current Biology.

[28]  J. McCubrey,et al.  Effects of deregulated RAF and MEK1 expression on the cytokine-dependency of hematopoietic cells. , 2000, Advances in enzyme regulation.

[29]  J. McCubrey,et al.  Synergy between Raf and BCL2 in abrogating the cytokine dependency of hematopoietic cells , 2000, Leukemia.

[30]  J. McCubrey,et al.  Combined effects of aberrant MEK1 activity and BCL2 overexpression on relieving the cytokine dependency of human and murine hematopoietic cells , 2000, Leukemia.

[31]  D. B. Evans,et al.  The N-terminal domains of cyclin-dependent kinase inhibitory proteins block the phosphorylation of cdk2/Cyclin E by the CDK-activating kinase. , 2000, Biochemical and biophysical research communications.

[32]  R. Medema,et al.  AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1 , 2000, Nature.

[33]  M. Martínez-Lorenzo,et al.  Tyrosine phosphorylation of the p85 subunit of phosphatidylinositol 3-kinase correlates with high proliferation rates in sublines derived from the Jurkat leukemia. , 2000, The international journal of biochemistry & cell biology.

[34]  J. McCubrey,et al.  Differential abilities of the Raf family of protein kinases to abrogate cytokine dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism , 2000, Leukemia.

[35]  J. McCubrey,et al.  A conditionally-active form of MEK1 results in autocrine transformation of human and mouse hematopoietic cells , 2000, Oncogene.

[36]  J. McCubrey,et al.  Serine/threonine phosphorylation in cytokine signal transduction , 2000, Leukemia.

[37]  B. Calabretta,et al.  Multiple Signaling Pathways of the Insulin-Like Growth Factor 1 Receptor in Protection from Apoptosis , 1999, Molecular and Cellular Biology.

[38]  J. McCubrey,et al.  Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs , 1999, Leukemia.

[39]  J. Downward,et al.  Multiple Ras Effector Pathways Contribute to G1Cell Cycle Progression* , 1999, The Journal of Biological Chemistry.

[40]  R. Adam,et al.  The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells. , 1999, Cancer research.

[41]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[42]  B. Calabretta,et al.  Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt. , 1999, Cancer research.

[43]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[44]  M. Herlyn,et al.  Contribution of phosphatidylinositol 3‐kinase to radiation resistance in human melanoma cells , 1999, Molecular carcinogenesis.

[45]  J. McCubrey,et al.  Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells , 1998, Leukemia.

[46]  Kenneth M. Yamada,et al.  Tumor Suppressor PTEN Inhibits Integrin- and Growth Factor–mediated Mitogen-activated Protein (MAP) Kinase Signaling Pathways , 1998, The Journal of cell biology.

[47]  R. Kolesnick,et al.  BAD Enables Ceramide to Signal Apoptosis via Ras and Raf-1* , 1998, The Journal of Biological Chemistry.

[48]  M. Wigler,et al.  The lipid phosphatase activity of PTEN is critical for its tumor supressor function. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[49]  N. Rosen,et al.  Cyclin D Expression Is Controlled Post-transcriptionally via a Phosphatidylinositol 3-Kinase/Akt-dependent Pathway* , 1998, The Journal of Biological Chemistry.

[50]  José Luis de la Pompa,et al.  Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN , 1998, Cell.

[51]  B. Calabretta,et al.  Expression of Constitutively Active Raf-1 in the Mitochondria Restores Antiapoptotic and Leukemogenic Potential of a Transformation-deficient BCR/ABL Mutant , 1998, The Journal of experimental medicine.

[52]  Tomohiko Maehama,et al.  The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate* , 1998, The Journal of Biological Chemistry.

[53]  S. Brüsselbach,et al.  Abrogation of c-Raf expression induces apoptosis in tumor cells , 1998, Oncogene.

[54]  H. Abboud,et al.  PI-3-kinase and MAPK regulate mesangial cell proliferation and migration in response to PDGF. , 1997, American journal of physiology. Renal physiology.

[55]  S. R. Datta,et al.  Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.

[56]  E. Lees,et al.  Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1 , 1997, Molecular and cellular biology.

[57]  M. Wigler,et al.  PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.

[58]  A. Lloyd,et al.  Cooperating oncogenes converge to regulate cyclin/cdk complexes. , 1997, Genes & development.

[59]  G. Evan,et al.  Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB , 1997, Nature.

[60]  John Calvin Reed,et al.  Bcl-2 Targets the Protein Kinase Raf-1 to Mitochondria , 1996, Cell.

[61]  L. Neckers,et al.  Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. , 1996, Cancer research.

[62]  F. Dumont,et al.  Mechanism of action of the immunosuppressant rapamycin. , 1995, Life sciences.

[63]  L. Neckers,et al.  Taxol induction of p21WAF1 and p53 requires c-raf-1. , 1995, Cancer research.

[64]  S. Elledge,et al.  Inhibition of cyclin-dependent kinases by p21. , 1995, Molecular biology of the cell.

[65]  K Y Hui,et al.  A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). , 1994, The Journal of biological chemistry.

[66]  David Beach,et al.  p21 is a universal inhibitor of cyclin kinases , 1993, Nature.

[67]  A. Arcaro,et al.  Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. , 1993, The Biochemical journal.

[68]  J. McCubrey,et al.  Growth-promoting effects of insulin-like growth factor-1 (IGF-1) on hematopoietic cells: overexpression of introduced IGF-1 receptor abrogates interleukin-3 dependency of murine factor-dependent cells by a ligand-dependent mechanism. , 1991, Blood.